Literature DB >> 28170382

The double edge of cancer immunotherapy.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28170382     DOI: 10.1038/nm.4286

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

Authors:  Douglas B Johnson; Ryan J Sullivan; Patrick A Ott; Matteo S Carlino; Nikhil I Khushalani; Fei Ye; Alexander Guminski; Igor Puzanov; Donald P Lawrence; Elizabeth I Buchbinder; Tejaswi Mudigonda; Kristen Spencer; Carolin Bender; Jenny Lee; Howard L Kaufman; Alexander M Menzies; Jessica C Hassel; Janice M Mehnert; Jeffrey A Sosman; Georgina V Long; Joseph I Clark
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

Review 2.  Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies.

Authors:  E H Warren; H J Deeg
Journal:  Tissue Antigens       Date:  2013-04

Review 3.  Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

Authors:  Jianda Yuan; Priti S Hegde; Raphael Clynes; Periklis G Foukas; Alexandre Harari; Thomas O Kleen; Pia Kvistborg; Cristina Maccalli; Holden T Maecker; David B Page; Harlan Robins; Wenru Song; Edward C Stack; Ena Wang; Theresa L Whiteside; Yingdong Zhao; Heinz Zwierzina; Lisa H Butterfield; Bernard A Fox
Journal:  J Immunother Cancer       Date:  2016-01-19       Impact factor: 13.751

4.  Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.

Authors:  Krista Dubin; Margaret K Callahan; Boyu Ren; Raya Khanin; Agnes Viale; Lilan Ling; Daniel No; Asia Gobourne; Eric Littmann; Curtis Huttenhower; Eric G Pamer; Jedd D Wolchok
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

  4 in total
  1 in total

Review 1.  Immunology of tissue homeostasis, ovarian cancer growth and regression, and long lasting cancer immune prophylaxis - review of literature.

Authors:  Antonin Bukovsky
Journal:  Histol Histopathol       Date:  2020-09-08       Impact factor: 2.303

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.